Search Results

Valid until canceled 7 day free trial Select Watch 4 New Courses Each Month Connect in a Private Drug Explore : Foundational Lessons — Build Your Pharmacology Core Emerging Drug Hunter — Expand Your Edge

. ➡ https:// www.ecosystem.drgpcr.com/gpcr-binders-drugs-and-more/design-of-allosteric-modulators-that-change-gpcr-g-protein-subtype-selectivity

Interdisciplinary Research & Future Directions – Exploring combinatorial drug actions, receptor interactions In 2021 he co-founded Z7 Biotech, developing and providing innovative GPCR drug screening and precision

The way signals are organized defines specificity, drug response, and potential for targeted therapies

He also discovered and championed a novel prostaglandin EP4 drug candidate for development.

Optimization of Candidate Selection 📖 The five-lecture series describes essential additional elements to GPCR discovery programs that extend the discovery process and increase therapeutic opportunity. Optimization of Candidate Selection 📖 The five-lecture series describes essential additional elements to GPCR discovery programs that extend the discovery process and increase therapeutic opportunity. ✳️ Register today!

Scientists and Engineers working at the nanoscale, specifically protein engineering and small molecule drug

nervous system ADGRCs in glutamatergic synapse formation, maintenance and degeneration Yimin Zou Antibody-drug Yimin Zou on the web UC San Diego Antibody-drug conjugates targeting CD97 in glioblastoma Dimitris Placantonakis To exploit this expression profile, we have developed antibody-drug conjugates (ADCs) targeting CD97,

Pierre Eftekhari "Clinical physiologist and biologist , with more than 25 years of experience in drug

Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Structure-based discovery

motivated and inspired 🚀 Don’t miss this insightful conversation on GPCRs, pharmacology, and scientific discovery motivated and inspired 🚀 Don’t miss this insightful conversation on GPCRs, pharmacology, and scientific discovery

Focus on study of drugs and toxins on GPCR (opioid, cannabinoid receptor) and ion channel (K, Ca, TRP

molecular dynamics simulation methods with emphasis on application to G-protein coupled receptors and drug

and identification of small molecule regulators of these proteins, and progressing such ligands in drug

Dr Stagg has served as an expert consultant in the development of adenosine-targeting drugs, several

Pydi's laboratory is to develop GPCR-based drugs for the treatment of obesity and Type 2 Diabetes (T2D

Lauren Slosky is an Assistant Professor in the Department of Pharmacology and a member of the Medical Discovery within the University of Minnesota’s Medical School to advance research and treatment in the field of drug

Umeå, Sweden), I broadened my methodical and scientific horizon and focused on cellular metabolism and drug Metabolite Activation of GPCRs: A Fascinating Discovery Claudia and Yamina discussed the role of metabolites

ultimate aim is to use the new knowledge to find, create and optimize Frizzled-targeting small molecule drugs

of the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug

you the clarity and confidence to make better decisions—starting with: • The role of pharmacology in discovery you the clarity and confidence to make better decisions—starting with: 🟢 The role of pharmacology in discovery

Home About Services News Get in Touch Welcome Biotech Growth Wherever You Are in Discovery—Let’s Build Start My Discovery Plan Too Much Uncertainty, Not Enough Progress You’re not alone. How I Help Biotechs Accelerate GPCR Discovery with Clarity, Speed & Confidence Decisions, Not More Data Distill discovery progress into board-ready insights Craft milestone updates that tie data to strategy Start My Discovery Plan Send me a message First name* Last name Company name* Email* How Can I Help?

These mice can then be used to test dietary regimens, drugs, and adenoviral gene therapies for their

of the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug

GPCR Podcast Strategic Partners Signals, pH, and Discovery : Cracking GPCR Mysteries with Dr.

Join industry leaders as they share insights, stories, and groundbreaking discoveries, enriching our Exploring discoveries, careers, and ideas shaping human health. In each episode, we sit down with leading experts to explore their career journeys, groundbreaking discoveries GPCR Podcast was created with three goals: Share discoveries – Highlight the latest advances in the GPCR Fill out this form Be our Guest In each episode, we chat with an expert about their career trajectory, discoveries

Demet explained that since the year 2000, the field has seen significant growth, with important discoveries also discussed the importance of the extracellular region of these receptors and its potential as a drug

name mispronunciations, cultural differences, and the importance of a multidisciplinary approach in drug discussed their professional backgrounds, highlighting the benefits of a multidisciplinary approach in drug

I then pressed record, and we chatted for almost 2h about Bob’s career, discoveries, difficulties (yes His legacy lies in the numerous discoveries he and his team made in the GPCR field and in all those who

The Voice of the Community Whether you’re a scientist, student, or just curious, you’ll hear about discoveries